Solids
Product Description
Recipharm
-
SE -
2015On CPHI since
-
5000+Employees
Company types
Categories
Recipharm
-
SE
-
2015On CPHI since
-
5000+Employees
Company types
More Products from Recipharm (21)
-
Product Recipharm Inhalation Solutions™
Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture.Our dedicated team offers pharmaceutical companies a seamless outsourcing service from early stage development through to commercial manufacturing... -
Product Recipharm Analytical Solutions™
Through Recipharm Analytical Solutions™, we support customers with stand-alone analytical requirements. Our analytical development team has experience from developing hundreds of analytical methods every year, supporting development of formulations ranging from powder in capsules and IV solutions to ER tab... -
Product Injectables
Recipharm has extensive experience in the injectables area and supplies small volume parenterals in ampoules and vials, as well as in cartridges. State of the art leak detection and automatic inspection equipment is used and Recipharm’s full service offering is complete with secondary packaging and tempera... -
Product Ophthalmics
Recipharm offers pharmaceutical contract development and manufacturing in ophthalmics including, sterile manufacturing of eye and ear drops in plastic multi-dose containers and blow-fill-seal technology for single and as multi-dose use. -
Product Liquids
Recipharm offers pharmaceutical contract development and manufacturing of liquids, sprays and aerosols, with a broad range of equipment and compounding vessels from 100L to 5000L. -
Product Semi-solids
Recipharm offers pharmaceutical contract development and manufacturing of semi-solids including, APIs, creams, emulsions, gels, ointments, aerosols and suppositories. We have the capability to fill products in aluminum tubes, plastic tubes, syringes, aluminum cans, PVC or aluminum blist... -
Product Auto-injectors
We keep both the end-user and our pharmaceutical partners at the forefront of our product design, producing injection devices created to facilitate patient-friendly administration and overcome formulation challenges, particularly for high viscosity formulations. -
Product Nasal Sprays
At Recipharm we deliver market-leading design, development, and manufacturing services for nasal spray devices to the global pharmaceutical market. -
Product pMDIs
Deliver precise and effective treatments to your patients by partnering with Recipharm for your pMDI products. Backed by over 60 years of experience, we have overcome many pMDI product development challenges to provide you with high quality products. -
Product Soft Mist Inhalers
The Resyca soft mist inhaler is a joint venture between Recipharm and Medspray and uses proprietary spray nozzle technology to deliver next-generation SMIs that deliver an aerosol from a liquid solution. -
Product Development & manufacture - drug delivery devices
Bespak by Recipharm delivers market leading design, development, and manufacturing services for drug delivery devices to the global pharmaceutical market. Our portfolio includes inhalers, nasal technologies, and auto-injectors as well as development and manufacturing services.
Recipharm resources (8)
-
News Sustainability in pharmaceutical manufacturing: an expert panel discussion
In this written panel discussion experts in manufacturing in the pharmaceutical supply chain comment on the manufacturing landscape, how sustainable practices are being incorporated more readily, the challenges associated with this and the overall advantages. -
Brochure Recipharm's full service offering
Your innovative drug. Our world-class production facilities. Discover the genius of working together. -
News Recipharm receives approval for the manufacture of a new microbiome-based therapeutic
Recipharm receives regulatory approval for the manufacture of a microbiome-based product for the prevention of Clostridioides difficile recurrent infection, under GenIbet Biopharmaceuticals and Seres Therapeutics. -
News Watch now: Pharma Trends 2022 Webinar
We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event. -
News Lyophilisation technology improving thermal stability and reducing cycle times, says Recipharm expert
Lyophilisation or freeze drying is an important means to improve thermal stability of a drug product, according to Thomas Becker, Quality Director and Qualified Person, Recipharm. This is particularly true for those that are thermolabile, such as mRNA vaccine candidates.
-
Sponsored Content Key considerations to develop effective analytical methods for your drug project
A summary exploring Recipharm’s key considerations when it comes to developing effective analytical methods for drug projects. -
News CPHI Podcast Series: Selecting the Right CDMO Outsourcing Partner
With so many outsourcing options available, selecting the CDMO that is the right fit for any particular sponsor company can be a challenging task. -
News Sterile manufacturing Annex 1 amendments: what, why and how explained
In January 2020 the European Commission published some proposed significant revisions to Annex 1, the EU’s good manufacturing practice (GMP) guide for the manufacture of sterile products. In the following three-month consultation period, affected organisations and stakeholders from over 70 different countries submitted more than 2,000 comments to the proposed update.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance